Impact of Perioperative Hyperoxia on Cancer Recurrence and Mortality After Elective Colorectal Cancer Surgery

NCT06989346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2025-05-25

No results posted yet for this study

Summary

The goal of this observational study is to evaluate whether perioperative hyperoxia (FiO₂ \> 0.8), compared to conventional oxygen therapy (FiO₂ \< 0.4), is associated with increased cancer recurrence and mortality in patients undergoing curative elective colorectal cancer surgery.

Conditions

  • Recurrence
  • Survival Rate
  • Mortality
  • Colorectal Surgery
  • Hyperoxia

Sponsors & Collaborators

  • Parc de Salut Mar

    lead OTHER

Principal Investigators

  • Marc Sadurní, MD · Hospital del Mar

  • Laura Castelltort, MD · Hospital del Mar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-17
Primary Completion
2024-12-17
Completion
2025-04-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989346 on ClinicalTrials.gov